These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 2056801

  • 21. Paricalcitol, a new agent for the management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis.
    Goldenberg MM.
    Clin Ther; 1999 Mar; 21(3):432-41. PubMed ID: 10321413
    [Abstract] [Full Text] [Related]

  • 22. Successful use of zero calcium dialysate to treat hypercalcemia in a postsurgical peritoneal dialysis patient.
    Mars RL.
    Adv Perit Dial; 1993 Mar; 9():284-7. PubMed ID: 8105944
    [Abstract] [Full Text] [Related]

  • 23. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
    Audran M, Minebois-Villégas A, Lortholary A, Legrand E, Pascaretti C, Giraud P, Subra JF, Boasson M, Jallet P.
    Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
    [Abstract] [Full Text] [Related]

  • 24. Hypercalcemia secondary to chronic renal failure in the dog: a report of four cases.
    Finco DR, Rowland GN.
    J Am Vet Med Assoc; 1978 Oct 15; 173(8):990-4. PubMed ID: 721683
    [Abstract] [Full Text] [Related]

  • 25. RenaGel efficacy in severe secondary hyperparathyroidism.
    Castro R, Herman A, Ferreira C, Travassos F, Nunes-Azevedo J, Oliveira M.
    Nefrologia; 2002 Oct 15; 22(5):448-55. PubMed ID: 12497746
    [Abstract] [Full Text] [Related]

  • 26. [Kidney failure as a consequence of sarcoidosis].
    Schindlbeck NE, Lechner M, Scherer B.
    Dtsch Med Wochenschr; 1992 Mar 27; 117(13):494-8. PubMed ID: 1551374
    [Abstract] [Full Text] [Related]

  • 27. [Usefulness of calcium acetate as a chelating of phosphorus in patients in hemodialysis with secondary hyperthyroidism].
    Torregrosa Prats JV, Mas Mas M, Montesinos Ballestena M, Casellas Bartumeus J, Campistol Plana JM.
    An Med Interna; 1995 Aug 27; 12(8):377-81. PubMed ID: 8924527
    [Abstract] [Full Text] [Related]

  • 28. Recurrent hepatic sarcoidosis post-liver transplantation manifesting with severe hypercalcemia: a case report and review of the literature.
    Cengiz C, Rodriguez-Davalos M, deBoccardo G, Fiel MI, Rodriguez-Laiz G, Kovacevic M, Emre S, Schiano T.
    Liver Transpl; 2005 Dec 27; 11(12):1611-4. PubMed ID: 16315309
    [Abstract] [Full Text] [Related]

  • 29. Hypercalcemia and renal failure in the course of sarcoidosis--case report.
    Kempisty A, Kuś J.
    Pneumonol Alergol Pol; 2012 Dec 27; 80(6):570-5. PubMed ID: 23109211
    [Abstract] [Full Text] [Related]

  • 30. Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results.
    Coen G, Mazzaferro S, Bonucci E, Ballanti P, Massimetti C, Donato G, Landi A, Smacchi A, Della Rocca C, Cinotti GA.
    Miner Electrolyte Metab; 1986 Dec 27; 12(5-6):375-82. PubMed ID: 3492662
    [Abstract] [Full Text] [Related]

  • 31. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.
    Hamano T, Oseto S, Fujii N, Ito T, Katayama M, Horio M, Imai E, Hori M.
    Bone; 2005 May 27; 36(5):909-16. PubMed ID: 15794928
    [Abstract] [Full Text] [Related]

  • 32. [Sarcoidosis with hypercalcemia and increased 1 alpha, 25-dihydroxyvitamin D in lung tissue].
    Fujita A, Suzuki A, Kashiyama T, Watanabe A, Kimura H.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug 27; 33(8):900-5. PubMed ID: 7474574
    [Abstract] [Full Text] [Related]

  • 33. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
    Ross EA, Tian J, Abboud H, Hippensteel R, Melnick JZ, Pradhan RS, Williams LA, Hamm LL, Sprague SM.
    Am J Nephrol; 2008 Aug 27; 28(1):97-106. PubMed ID: 17914251
    [Abstract] [Full Text] [Related]

  • 34. Denosumab for the treatment of bisphosphonate resistant hypercalcemia in a hemodialysis patient.
    Dahmani O, Sophoclis C, Kebir M, Bouguern D, Sakho A, Demarchi P.
    Saudi J Kidney Dis Transpl; 2017 Aug 27; 28(1):154-157. PubMed ID: 28098117
    [Abstract] [Full Text] [Related]

  • 35. Renal manifestations of sarcoidosis.
    Muther RS, McCarron DA, Bennett WM.
    Arch Intern Med; 1981 Apr 27; 141(5):643-5. PubMed ID: 7224744
    [Abstract] [Full Text] [Related]

  • 36. Renal insufficiency in sarcoidosis. A clinical and pathologic study.
    McCurley T, Salter J, Glick A.
    Arch Pathol Lab Med; 1990 May 27; 114(5):488-92. PubMed ID: 2334257
    [Abstract] [Full Text] [Related]

  • 37. [Acute hypercalcemia syndrome in sarcoidosis].
    Kuhn M, Widder W, Gartmann J, Hartmann G.
    Schweiz Med Wochenschr; 1985 Sep 28; 115(39):1365-7. PubMed ID: 3840913
    [Abstract] [Full Text] [Related]

  • 38. [Metabolism of calcium in sarcoidosis].
    Podwysocki B.
    Postepy Hig Med Dosw; 1994 Sep 28; 48(2):193-206. PubMed ID: 7937400
    [Abstract] [Full Text] [Related]

  • 39. [How should we manage serum calcium concentration in an hemodialysed patient?].
    Houillier P.
    Nephrol Ther; 2005 Dec 28; 1 Suppl 4():S330-6. PubMed ID: 17373204
    [Abstract] [Full Text] [Related]

  • 40. Hypercalcemia and nephrolithiasis provoked by serum phosphorus reduction in a patient with chronic renal failure and sarcoidosis.
    Caruana RJ, Weinstein RS.
    Nephron; 1983 Dec 28; 33(4):271-3. PubMed ID: 6843758
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.